These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11060477)

  • 21. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.
    Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A;
    Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.
    Paille FM; Guelfi JD; Perkins AC; Royer RJ; Steru L; Parot P
    Alcohol Alcohol; 1995 Mar; 30(2):239-47. PubMed ID: 7662044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficient prevention of relapse with acamprosate].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2000 Jun; 23(6):206-7. PubMed ID: 10950666
    [No Abstract]   [Full Text] [Related]  

  • 28. A literature review of cost-benefit analyses for the treatment of alcohol dependence.
    Popova S; Mohapatra S; Patra J; Duhig A; Rehm J
    Int J Environ Res Public Health; 2011 Aug; 8(8):3351-64. PubMed ID: 21909311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.
    Colagiuri B; Morley K; Boakes R; Haber P
    Psychother Psychosom; 2009; 78(3):167-71. PubMed ID: 19270472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acamprosate campral for alcoholism.
    Med Lett Drugs Ther; 2005 Jan; 47(1199):1-3. PubMed ID: 15599336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):55-8. PubMed ID: 9845038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gambling on acamprosate: a case report.
    Raj YP
    J Clin Psychiatry; 2010 Sep; 71(9):1245-6. PubMed ID: 20923626
    [No Abstract]   [Full Text] [Related]  

  • 34. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acamprosate for the adjunctive treatment of alcohol dependence.
    Overman GP; Teter CJ; Guthrie SK
    Ann Pharmacother; 2003; 37(7-8):1090-9. PubMed ID: 12841823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
    Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
    [No Abstract]   [Full Text] [Related]  

  • 38. Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.
    Kiefer F; Witt SH; Frank J; Richter A; Treutlein J; Lemenager T; Nöthen MM; Cichon S; Batra A; Berner M; Wodarz N; Zimmermann US; Spanagel R; Wiedemann K; Smolka MN; Heinz A; Rietschel M; Mann K
    Pharmacogenomics J; 2011 Oct; 11(5):368-74. PubMed ID: 20585342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():55-8. PubMed ID: 8737001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.